CLINICAL_TRIALS
trial_result
· 2017-04-06
Clinical Trial Update: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B. [Phase 4]
Summary
A Phase 4 study evaluating Pegasys (peginterferon alfa-2a) for chronic hepatitis B has completed and results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Hoffmann-La Roche | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED | Results posted: 2017-04-06